Selegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chun-feng Liu, MD,PhD
Second Affiliated Hospital of Soochow University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Changshu Hospital Affiliated To Nanjing University of Chinese Medicine
Changshu, Jiangsu, China
- Second Affiliated Hospital of Nantong University
Nantong, Jiangsu, China
- Department of Neurology, Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
- Jiang Yuan Hospital Affiliated To Jiangsu Institute of Nuclear Medicine
Wuxi, Jiangsu, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Mar 2020
- Primary completion
- 31 Dec 2020
- Completion
- 30 Apr 2021
- Last update posted
- 7 May 2021
- Registered enrollment
- 141
- Registry id
- NCT04870372
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.